We help you determine if the cancer in your family is sporadic, familial or hereditary. This can provide you with the information you need to create a plan for early detection and/or reducing the risk of developing cancer for you or others in your family.
Hoag leads innovative clinical trials, including immunotherapy agents, all pushing for more advanced, effective care for colorectal cancer patients.





Hoag Memorial Hospital Presbyterian

Hoag Health Center Irvine - Sand Canyon

Hoag Memorial Hospital Presbyterian

Hoag Health Center - Huntington Beach
Get care from medical providers that fit your needs in a location near you.
Find a providerFind information made to guide and support you on your journey. 
See all resourcesDidn’t see what you’re looking for? Reach out and we’ll make sure you get what you need. 
Contact usNearly all colon cancers begin as benign polyps that slowly develop into cancer. In many cases, colorectal cancer symptoms do not appear until the tumor is large. That is why screening colonoscopy is so critical in detecting polyps before they have turned into cancer. The symptoms of colorectal cancer include:
Pain and tenderness in the abdomen
Diarrhea, constipation or changes in bowel movements
Blood in the stool, or narrow stools
Weight loss for unknown reasons Download this helpful screening guide for Colorectal Cancer and other prevalent cancer screenings.
Research has shown that some risk factors are present for developing colorectal cancer. These colorectal cancer risk factors include:
Age – More than 90 percent of people with this disease are diagnosed after age 50. The average age of diagnosis is mid 60’s.
Colorectal polyps – Most polyps are benign, but some can be cancerous. Consistently finding and removing polyps can reduce the risk of colorectal cancer. Oftentimes, polyps are what become cancer.
A family history – individuals who have close relatives with a history of colorectal cancer are more likely to develop the disease themselves.
Behavioral risk factors – Including tobacco and alcohol, physical inactivity and obesity
As mentioned above, a risk for colorectal cancer could be family history. About 10% of colon cancer cases are due to an inherited genetic susceptibility. Hereditary colon cancer can be divided into two broad categories: polyposis (many polyps) and nonpolyposis syndromes (few or no polyps). Familial adenomatous polyposis (FAP) and MYH-associated polyposis (MAP) are the most prevalent of the former category, and Lynch syndrome (LS) is the most common of the latter. Features of hereditary colon cancer susceptibility in a family include one or more of the following: individuals with multiple colorectal polyps, multiple relatives on the same side of the family with colon or other LS-related cancers (rectal, uterine, ovarian, renal, or other gastrointestinal cancers), individuals with more than one primary tumor, and colon cancer diagnosed under age 50.
Colorectal cancer can be avoided if routine proper screening takes place. Hoag Family Cancer Institute recommends routine screening colonoscopies for men and women beginning at age 50, with subsequent intervals for retesting as determined by a physician.
The gold standard in colorectal cancer screening is colonoscopy. A traditional screening colonoscopy is a short outpatient procedure that uses a flexible endoscope to travel through the colon to most accurately visualize abnormalities or polyps, and look for early signs of colorectal cancer. During the procedure, suspicious polyps can be removed, substantially reducing the risk of colorectal cancer over a patient’s lifetime.
While there are other screening options, such as a virtual screening colonoscopy – which utilizes CT scanning to detect polyps – non are superior to a conventional colonoscopy. Individuals receive a virtual colonoscopy for special circumstances, such as being too sick or weak for the more invasive conventional colonoscopy or being on blood thinners. However, if during a virtual colonoscopy a polyp or suspicious mass is detected, that individual will still need to go through a conventional colonoscopy to remove the polyp.
A conventional screening colonoscopy also acts as a means of colorectal cancer diagnosis. The polyps removed during a screening colonoscopy are biopsied to ensure that there are no signs of precancerous or cancerous changes.
Hoag Family Cancer Institute offers a variety of innovative and progressive treatment options to colorectal cancer patients. Our goal is to tailor treatment plans to each individual, to accurately and effectively treat your disease. Hoag’s colorectal cancer experts specialize in surgical and radiation therapies for colorectal cancer.
If colon cancer is detected during a colonoscopy, additional tests will be performed to determine if the cancer has spread. CT or PETscans may be utilized to help stage the cancer, and help determine the treatment path.
Surgery is the main treatment option for colon cancer. During surgery, the section of the colon that contains the cancerous tumor along with the adjacent lymph nodes will be removed,. Hoag’s skilled surgeons utilize two minimally invasive techniques for colon cancer surgery. These include:
Laparoscopic surgery
Robotic-assisted surgery
Both are excellent, effective surgical techniques for safely removing cancer cells. The surgical technique will be selected depending on the patient, their stage of cancer and location.
Once the cancer is surgically removed from the colon, a pathology report will determine if other treatment options are needed, such as chemotherapy. This is called adjuvant therapy – a secondary therapy that follows the primary treatment to improve results.
If rectal cancer is detected during a screening colonoscopy, additional tests may be completed to determine if the cancer has spread outside the rectum. Utilizing CT, PET, or MRI imaging, your physician can determine the best treatment path for your rectal cancer.
Rectal cancer is traditionally treated using a mix of therapies – surgery, radiation therapy and chemotherapy. Due to the location of the rectum, treatment often begins with less invasive options such as radiation therapy and chemotherapy to shrink the size of the tumor and allow for preservation of the anal sphincter. This treatment before surgery is referred to as neoadjuvant therapy. A skilled Hoag surgeon will then surgically remove the remaining concerning areas of the rectal cancer.
Hoag’s skilled surgical team offers minimally invasive treatment options for rectal cancer, including:
Laparoscopic surgery
Robotic-assisted surgery

Dr. Daniel Ng is a colon and rectal surgeon in Newport Beach, California. He received his medical degree from University of California Davis School of Medicine and has been in practice for more than 20 years.

William Oh, M.D., F.A.C.S., F.A.S.C.R.S. is double board certified in general surgery as well as colon and rectal surgery. He attended Cornell University’s College of Human Ecology, receiving his bachelor’s degree in human biology, health and society with a concentration in gerontology. He developed an interest in geriatric medicine and went to New York Medical College to obtain his medical degree. During his surgery rotation, Dr. Oh’s plans shifted to becoming a surgeon after observing the on-call surgical team perform an operation on a young patient experiencing acute appendicitis. Once he saw the patient walk out of the hospital, he felt the joy that comes from directly helping a patient utilizing surgery. Dr. Oh completed his general surgery residency at UCSF-Fresno in Fresno, CA, where he developed a special interest in the disease of the colon and rectum. During his time at UCSF-Fresno, he was honored with multiple awards including UCSF Fresno Steven N. Parks Golden Scalpel Award for Outstanding Senior Resident and UCSF Fresno Resident Excellence in Teaching Award. Following his residency, he pursued a colon and rectal surgery fellowship at Indiana University in Indianapolis, IN, with extensive emphasis on minimally invasive surgical techniques using laparoscopy and the da Vinci® Xi robot. His expertise with the da Vinci® Xi robot has helped patients with colon cancer, rectal cancer, inflammatory bowel disease and rectal prolapse. He is also passionate about managing benign anorectal diseases such as hemorrhoids, anal fissure and anal fistula. Dr. Oh is a member of the American Society of Colon and Rectal Surgery, American College of Surgeons and American Medical Association. He has authored publications and delivered numerous presentations focused on a variety of topics including management of hemorrhoids and anal fissures, laparoscopic colectomies, benign anorectal diseases and enhanced recovery after surgery protocol to name a few.

Babak (Bobby) Rad, M.D., is a colon and rectal surgeon at Hoag Family Cancer Institute. He treats the full spectrum of anorectal (hemorrhoids, anal fissures, fistulas) and colon diseases (colon cancer, diverticular disease) and is especially interested in the treatment of colon and rectal cancer. Dr. Rad is a strong proponent of and advocate for the use of robotic surgery and minimally invasive techniques for treating colorectal cancer and is involved in clinical research through Hoag Family Cancer Institute. Dr. Rad earned the Orange County Physician of Excellence Award in 2021, 2023 and 2024. Dr. Rad graduated from the University of Southern California with a B.S. in biological sciences in 1991. After obtaining his medical degree from the Medical College of Pennsylvania in 1995, he completed a general surgery residency at the University of Medicine & Dentistry of New Jersey in 2000 where he was administrative chief resident and was awarded the Golden Apple teaching award twice. He then pursued additional fellowship training in colon and rectal surgery at the University of Southern California. Dr. Rad is dual-board certified in general and colorectal surgery, although his practice is limited to the specialty of colon and rectal surgery. He is a Fellow of the American College of Surgeons and a Fellow of the American Society of Colon and Rectal Surgeons. Dr. Rad has been practicing in Orange County/Newport Beach since 2001. In his spare time, he enjoys spending time with his family, working out, reading, traveling and Formula 1 racing.

Elizabeth R. Raskin, M.D., is Surgical Director for the Margolis Family Inflammatory Bowel Disease (IBD) Program within the Digestive Health Institute at Hoag. A colorectal surgeon with approximately 20 years of experience advancing state-of-the-art technologies and innovative surgical techniques, Dr. Raskin understands the importance of how medical care is delivered and provides cutting-edge, comprehensive care to provide better surgical treatment and improved patient recovery. Specializing in the treatment of complex colon, rectal and anal conditions, including laparoscopic and robot-assisted surgical techniques, Dr. Raskin believes we must use our experience, instinct and imagination to reach beyond traditional boundaries to pave the way for better healthcare today and tomorrow. Skilled in minimally invasive surgery, she has a keen interest in examining how robotic surgery and developing technologies can improve patient treatment options and outcomes. As a researcher, Dr. Raskin has specific interests in IBD, complex diverticular disease, and ostomy creation and care. She has written and contributed to numerous peer-reviewed publications and textbooks and has presented multiple national and international lectures on a wide array of colorectal topics. Dr. Raskin lectures, teaches and trains surgeons of all levels, allied health representatives and industry on robotics. As a perpetual student, Dr. Raskin is uniquely interested in energy medicine and functional healing as an adjunct to surgical care.

Medical Director of Cancer Research for Hoag Family Cancer Institute

<p>Tara Seery, M.D., attended University College Dublin School of Medicine followed by an internship at Mater Misericordiae Hospital as well as an internship and residency at Caritas St. Elizabeth Medical Center in Boston. She then completed fellowships in hematology/oncology at both Caritas St. Elizabeth Medical Center and University of Illinois at Chicago. Dr. Seery is board certified in Medical Oncology and Hematology.</p><p>Dr. Seery is particularly interested in GI oncology, including hepatobiliary cancers such as pancreatic, liver and bile duct cancers.</p><p>She has served as the primary investigator on several clinical research trials, co-authored numerous medical publications and abstracts, and edited multiple peer-reviewed journals. Additionally, she has given clinical presentations both across the U.S. and abroad. </p><p>Dr. Seery’s teaching experience spans the areas of medical and graduate level courses including a Hematology/Oncology Fellowship Annual Lecture Series on Pancreatic Cancer, Liver Cancer and the Management of Unresectable Hepatocellular Carcinoma at UC Irvine’s 5th Annual Gastroenterology and Hepatology Symposium. In addition, she oversaw a group of Hematology/Oncology Fellows at the University of California Irvine Outpatient Clinic.</p><p>Dr. Seery is a member of the American Society of Clinical Oncology and the American Society of Hematology.</p>

Executive Medical Director, Hoag Digestive Health Institute

Medical Director of Hoag Advanced Endoscopy Center, Gastroenterologist

Paul J. Korc, M.D. serves as medical director of the Hoag GI Lab and is a board-certified gastroenterologist with fellowship training in advanced endoscopic procedures. After completing his residency and fellowship at USC, he went on to spend a year at Indiana University, one of the nation’s top programs for biliary and pancreatic disorders. There, he received training in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS), gaining extensive experience in the management of complex cases. Dr. Korc’s expertise also includes removal of large polyps and early stage cancers of the gastrointestinal tract, using endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). He spent time in Seoul, Korea learning ESD, a cutting-edge technique in which pre-cancerous lesions and superficial cancers are removed en bloc (in one piece), avoiding the need for surgery. Additionally, Dr. Korc performs peroral endoscopic myotomy (POEM), a specialized procedure that restores the ability to eat and drink for people with achalasia, an esophageal motility disorder. Dr. Korc brings to Hoag his expertise in these procedures, some of which are available at only a handful of medical centers in Southern California. Dr. Korc offers patients compassionate, personalized care along with the very best advances in endoscopic treatment.
Hoag’s Precision Medicine Program combines genomics and genetics to diagnose, treat, and prevent diseases. Using the latest advances in genomic technologies, targeted therapies and research, our precision medicine program brings together a multidisciplinary team, including a robust genetic counseling group of experts, to provide patients with the latest in innovation and technology.
Hoag Family Cancer Institute provides a dedicated team of genetic counselors that offer hereditary cancer assessment, offering risk assessment and genetic cancer testing to those with a personal or family history of cancer.
Being diagnosed with cancer can feel overwhelming at times. Many patients and their families need help with coping and can benefit from supportive counseling. Oncology Clinical Social Workers are available to provide emotional and practical support during all stages of cancer including diagnosis, treatment and post-treatment survivorship.
Hoag Family Cancer Institute dietitians work closely with patients’ physicians, nurses, therapists, and social workers to ensure complete care.
Cancer Support Services offers a variety of classes to support and educate patients during and after cancer. These classes and workshops are all free of charge:
Gastrointestinal Cancer Support Group – Designed to meet the educational and emotional needs of gastrointestinal cancer patients and their families. The group meets the fourth Thursday of each month from 2-3:30 p.m. in the Hoag Cancer Center Conference Room A.
One-On-One Counseling with an oncology social worker
Fitter Image Exercise Programs, including yoga, pilates and energizing cardio and toning
Workshops for Well-Being, including free flow writing, meditation, reiki and creative art classes
CARES Program – For patients experiencing high pain or symptom burden during treatment, the Hoag CARES Team can help. Board-certified Palliative Care physicians, nurses and social workers are available to help manage physical and emotional symptoms alongside your cancer care team.
Oncology Dietitians – Hoag Family Cancer Institute provides two dedicated Registered Dietitians who are available to advise patients on nutrition and provide resources for a healthier diet before, during and after cancer treatment.
Hereditary Cancer Program – Hoag offers both genetic counseling and genetic testing for individuals concerned about hereditary cancer.
Spiritual Care – provides spiritual support & counseling services to patients, families, and the community.